Cargando…

Role of Intravitreal Bevacizumab in Management of Eale’s Disease

OBJECTIVE: To investigate the role of Intravitreal Bevacizumab (IVB), in preventing vitreo-retinal complications in patients of Eale’s Disease (ED). METHODS: This randomized control trial was conducted at Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi from May 2015 to December 2016. A to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehboob, Mohammad Asim, Tahir, Muhammad, Batool, Huma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954374/ https://www.ncbi.nlm.nih.gov/pubmed/29805403 http://dx.doi.org/10.12669/pjms.342.14483

Ejemplares similares

Intravitreal bevacizumab as an adjunct to vitrectomy in advanced Eales’ disease
por: Thakar, Meenakshi, et al.
Publicado: (2011)

Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
por: CP, Juarez, et al.
Publicado: (2013)

Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales’ Disease Associated With Latent Mycobacterium Tuberculosis
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Ultra-wide field angiography in the management of Eales disease
por: Kumar, Vinod, et al.
Publicado: (2016)

Eales' disease - current concepts in diagnosis and management
por: Biswas, Jyotirmay, et al.
Publicado: (2013)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
por: Hsia, Ning-Yi, et al.
Publicado: (2021)

Eales’ disease: epidemiology, diagnostic and therapeutic concepts
por: Murillo López, Sergio, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Eales disease: no typical clinical presentation
por: Adil, Belmokhtar, et al.
Publicado: (2014)

Papillophlebitis as an initial presentation of Eales' disease
por: Patel, Dhaval, et al.
Publicado: (2020)

Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview
por: Faisal, Syed Muhammad, et al.
Publicado: (2018)

Total antioxidant capacity in Eales’ disease, uveitis & cataract
por: Selvi, Radhakrishnan, et al.
Publicado: (2011)

Intravitreal bevacizumab: an analysis of the evidence
por: Smit, Derrick P, et al.
Publicado: (2007)

Progressive Nodular Histiocytosis Associated with Eale's Disease
por: Williams, Abhilasha, et al.
Publicado: (2015)

Unilateral Eales’ disease a case report
por: Nicolcescu, Andreea, et al.
Publicado: (2017)

Eales' Disease: When the Rare Sounds Frequent
por: Lopes, Beatriz Oliveira, et al.
Publicado: (2021)

Intravitreal administration of bevacizumab: pros and cons
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
por: Ahmed, Nasir, et al.
Publicado: (2021)

Meet Ealing District Local Association
Publicado: (1963)

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020)

Advanced Eales’ Disease With Neovascular Glaucoma at First Presentation
por: Alfayyadh, Mohammed A, et al.
Publicado: (2021)

Primary Effects of Intravitreal Bevacizumab in Patients with Diabetic Macular Edema
por: Tareen, Iftikhar-ul-Haq, et al.
Publicado: (2013)

The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018)

Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
por: Goel, Neha, et al.
Publicado: (2018)

Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales’ Disease
por: Ersöz, M. Giray, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)

Eales disease in a young adult man Case report
por: Călugăru, Dan, et al.
Publicado: (2017)

Double Trouble: Eales Disease in a Background of Paradoxical Embolism
por: Horvath, David, et al.
Publicado: (2023)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales’ disease
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2017)

A Long-Awaited Structure Is Rev-ealed
por: Hammarskjold, Marie-Louise, et al.
Publicado: (2011)

Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection
por: Ghassemi, Fariba, et al.
Publicado: (2017)

Resolution of macular edema in Coats' disease with intravitreal bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2010)

Response of Diabetic Papillopathy to Intravitreal Bevacizumab
por: Al-Dhibi, Hassan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4c3tn6nkntsc65887oltkojjk1